Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease | MicrobiomeTrials← Back to trialsNCT07619547
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-07-30Est. Completion: 2036-06-01
Enrollment target: 100 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Atrophic Gastritis
Chronic atrophic gastritis (CAG) is a common and frequently-occurring disease, characterized by atrophy of gastric mucos…
Hong Kong, Hong KongCompleted Nov 22, 2024
DysphagiaEosinophilic Esophagitis
Background:
Eosinophilic esophagitis (EoE) is a disease that causes inflammation in the esophagus. The esophagus is the…
Bethesda, United StatesEst. completion Aug 31, 2027
WITHDRAWN
Fistula in AnoCrohn Disease
Crohn's disease is a chronic inflammatory condition that can affect any part of the bowel which can be controlled by a c…
Multiple LocationsCompleted Jun 11, 2026